Sorafekast

Sorafenib Tablets IP 200 mg

Send Enquiry



Categories: ,
Description

Description

COMPOSITION: Each tablet contains Sorafenib 200 mg

INDICATION: SORAFEKAST is indicated for

  • Hepatocellular cell carcinoma that cannot be removed by surgery (Liver cancer)
  • Renal cell carcinoma (Kidney cancer)
  • Difierentiated Thyroid carcinoma (Thyroid cancer)

PACKING: 30 Tablets Bottle & 120 Tablets Bottle

Download Product PDF Attachment

Sorafekast

Download